Adiposity and clinical outcomes in East Asian patients with heart failure and preserved ejection fraction

被引:3
作者
Seki, Yuko [1 ,2 ]
Obokata, Masaru [1 ]
Harada, Tomonari [1 ]
Kagami, Kazuki [3 ]
Sorimachi, Hidemi [1 ]
Saito, Yuki [4 ]
Kato, Toshimitsu [1 ]
Ishii, Hideki [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Cardiovasc Med, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan
[2] Gunma Univ Hosp, Dept Radiol, Maebashi, Gumma, Japan
[3] Natl Def Med Coll, Div Cardiovasc Med, Tokorozawa, Saitama, Japan
[4] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan
来源
IJC HEART & VASCULATURE | 2023年 / 44卷
关键词
Computed tomography; Heart failure; Malnutrition; Obesity; Visceral fat; OBESE PHENOTYPE; MORTALITY; TISSUE; IMPACT; RISK;
D O I
10.1016/j.ijcha.2022.101162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the obesity paradox, visceral adiposity is associated with poor clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF). However, it remains unclear whether a relationship between visceral fat and clinical outcomes exists in Asian patients with HFpEF, in whom obesity is rare. Methods: Visceral and subcutaneous adipose tissue (VAT and SAT) volume and area were measured using computed tomography (CT) in 196 HFpEF patients. The primary endpoint was a composite of all-cause mortality or HF hospitalization. Results: Participants had a normal body mass index (BMI) (22.5 +/- 4.4 kg/m(2)), and obesity (BMI > 30 kg/m(2)) was rare (4.6 %). The primary outcome was observed in 64 patients during a median follow-up of 11.6 months. Lower VAT and SAT volumes were associated with underweight and malnutrition. Composite outcomes increased as body weight, BMI, and height-indexed SAT volume and area decreased. Lower height-indexed VAT volume and area were also associated with the outcomes. The height-indexed SAT area provided independent and incre-mental prognostic value over age, BMI, blood pressure, and creatinine and albumin levels. Conclusions: In lean East Asian patients with HFpEF, a lower VAT volume was associated with poorer clinical outcomes. CT-based assessments of adiposity may provide incremental prognostic value over simple anthropo-metric indices in lean HFpEF patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Heart failure with preserved ejection fraction
    Harper, Andrew R.
    Patel, Hitesh C.
    Lyon, Alexander R.
    CLINICAL MEDICINE, 2018, 18 (02) : S24 - S29
  • [32] Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
    Minamisawa, Masatoshi
    Claggett, Brian
    Suzuki, Kota
    Hegde, Sheila M.
    Shah, Amil M.
    Desai, Akshay S.
    Lewis, Eldrin F.
    Shah, Sanjiv J.
    Sweitzer, Nancy K.
    Fang, James C.
    Anand, Inder S.
    O'Meara, Eileen
    Rouleau, Jean-Lucien
    Pitt, Bertram
    Pfeffer, Marc A.
    Solomon, Scott D.
    Vardeny, Orly
    CIRCULATION-HEART FAILURE, 2021, 14 (11) : E008293
  • [33] Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Haass, Markus
    Kitzman, Dalane W.
    Anand, Inder S.
    Miller, Alan
    Zile, Michael R.
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION-HEART FAILURE, 2011, 4 (03) : 324 - 331
  • [34] Heart failure with preserved ejection fraction
    Rigolli, Marzia
    Whalley, Gillian A.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2013, 10 (04) : 369 - 376
  • [35] Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction
    Alogna, Alessio
    Koepp, Katlyn E.
    Sabbah, Michael
    Netto, Jair M. Espindola
    Jensen, Michael D.
    Kirkland, James L.
    Lam, Carolyn S. P.
    Obokata, Masaru
    Petrie, Mark C.
    Ridker, Paul M.
    Sorimachi, Hidemi
    Tchkonia, Tamara
    Voors, Adriaan
    Red, Margaret M.
    Borlaug, Barry A.
    JACC-HEART FAILURE, 2023, 11 (11) : 1549 - 1561
  • [36] Body Composition, Natriuretic Peptides, and Adverse Outcomes in Heart Failure With Preserved and Reduced Ejection Fraction
    Selvaraj, Senthil
    Kim, Jessica
    Ansari, Bilal A.
    Zhao, Lei
    Cvijic, Mary Ellen
    Fronheiser, Matthew
    Vanjarapu, Jagan Mohan-Rao
    Kumar, Anupam A.
    Suri, Arpita
    Yenigalla, Sowjanya
    Satija, Vaibhav
    Ans, Armghan Haider
    Narvaez-Guerra, Offdan
    Herrera-Enriquez, Karela
    Obeid, Mary Jo
    Lee, Jonathan J.
    Jehangir, Qasim
    Seiffert, Dietmar A.
    Car, Bruce D.
    Gordon, David A.
    Chirinos, Julio A.
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (01) : 203 - 215
  • [37] Epidemiological and clinical boundaries of heart failure with preserved ejection fraction
    Gentile, Francesco
    Ghionzoli, Nicolo
    Borrelli, Chiara
    Vergaro, Giuseppe
    Pastore, Maria Concetta
    Cameli, Matteo
    Emdin, Michele
    Passino, Claudio
    Giannoni, Alberto
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (08) : 1233 - 1243
  • [38] Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Dunlay, Shannon M.
    Roger, Veronique L.
    Weston, Susan A.
    Jiang, Ruoxiang
    Redfield, Margaret M.
    CIRCULATION-HEART FAILURE, 2012, 5 (06) : 720 - 726
  • [39] Predictors of two-year mortality in Asian patients with heart failure and preserved ejection fraction
    Yap, Jonathan
    Sim, David
    Lim, Choon Pin
    Chia, Shaw Yang
    Go, Yun Yun
    Jaufeerally, Fazlur Rehman
    Sim, Ling Ling
    Liew, Reginald
    Ching, Chi-Keong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 183 : 33 - 38
  • [40] Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction
    Brann, Alison
    Miller, James
    Eshraghian, Emily
    Park, Jin Joo
    Greenberg, Barry
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (10) : 1755 - 1765